Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses
Cardiovascular Therapeutics2021Vol. 2021, pp. 1–13
Citations Over TimeTop 14% of 2021 papers
Abstract
Our results provide further evidence for the potential use of Wog as an antioxidative agent for treatment of cardiac hypertrophy, and Nrf-2 might serve as a therapeutic target in the treatment of cardiac hypertrophy.
Related Papers
- → Anti-Hepatitis B Virus Effects of Wogonin Isolated from Scutellaria baicalensis(2000)97 cited
- → Inhibition of Mouse Liver Sialidase by the Root ofScutellaria baicalensis(1989)21 cited
- → Neuroprotective effect of Scutellaria baicalensis flavones against global ischemic model in rats(2015)8 cited
- → Neuroprotective effect of four flavonoids in the root of Scutellaria baicalensis Georgi(2012)4 cited